Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07CLV
|
|||
Former ID |
DIB018031
|
|||
Drug Name |
GDC-0152
|
|||
Synonyms |
GDC 0152; GDC0152
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Phase 1 | [1] | |
Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 1 | [2] | ||
Structure |
Download2D MOL
|
|||
Formula |
C25H34N6O3S
|
|||
Canonical SMILES |
CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C(=O)NC3=C(N=NS3)C4=CC=CC=C4)NC
|
|||
InChI |
1S/C25H34N6O3S/c1-16(26-2)22(32)27-21(18-12-7-4-8-13-18)25(34)31-15-9-14-19(31)23(33)28-24-20(29-30-35-24)17-10-5-3-6-11-17/h3,5-6,10-11,16,18-19,21,26H,4,7-9,12-15H2,1-2H3,(H,27,32)(H,28,33)/t16-,19-,21-/m0/s1
|
|||
InChIKey |
WZRFLSDVFPIXOV-LRQRDZAKSA-N
|
|||
CAS Number |
CAS 873652-48-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | X-linked inhibitor of apoptosis protein (XIAP) | Target Info | Modulator | [1] |
KEGG Pathway | NF-kappa B signaling pathway | |||
Ubiquitin mediated proteolysis | ||||
Apoptosis | ||||
Focal adhesion | ||||
Toxoplasmosis | ||||
HTLV-I infection | ||||
Pathways in cancer | ||||
Small cell lung cancer | ||||
Panther Pathway | Apoptosis signaling pathway | |||
Pathway Interaction Database | p75(NTR)-mediated signaling | |||
BMP receptor signaling | ||||
Caspase Cascade in Apoptosis | ||||
TGF-beta receptor signaling | ||||
Reactome | SMAC binds to IAPs | |||
SMAC-mediated dissociation of IAP:caspase complexes | ||||
Deactivation of the beta-catenin transactivating complex | ||||
RIPK1-mediated regulated necrosis | ||||
Regulation of TNFR1 signaling | ||||
TNFR1-induced NFkappaB signaling pathway | ||||
Regulation of necroptotic cell death | ||||
WikiPathways | Copper homeostasis | |||
Focal Adhesion | ||||
Apoptosis | ||||
Intrinsic Pathway for Apoptosis | ||||
Apoptosis Modulation and Signaling | ||||
NOD pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J Med Chem. 2012 May 10;55(9):4101-13. | |||
REF 2 | Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.Nat Rev Drug Discov. 2016 Aug;15(8):533-50. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.